Referred to existing researches, our analysis indicated that complicated ligand-receptor interactions worked within tumor microenvironment to regulate glioma malignancy and patient outcome, and expression of those factors was highly relevant to TNFSF13. The gene discussed is TNFSF13; the disease is central nervous system cancer.